BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12890202)

  • 21. Standardized AgNOR analysis in actinic keratosis.
    Tuccari G; Giuffrè G; Catalano A; Lentini M; Batolo D
    Am J Dermatopathol; 2001 Oct; 23(5):407-12. PubMed ID: 11801772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma antioxidant defense in actinic keratosis and basal cell carcinoma.
    Vural P; Canbaz M; Selçuki D
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):96-101. PubMed ID: 10568487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and endothelin-1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin ratio.
    Vural P; Erzengin D; Canbaz M; Selçuki D
    Int J Dermatol; 2001 Nov; 40(11):704-8. PubMed ID: 11737437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for actinic keratosis in eight European centres: a case-control study.
    Traianou A; Ulrich M; Apalla Z; De Vries E; Bakirtzi K; Kalabalikis D; Ferrandiz L; Ruiz-de-Casas A; Moreno-Ramirez D; Sotiriadis D; Ioannides D; Aquilina S; Apap C; Micallef R; Scerri L; Pitkänen S; Saksela O; Altsitsiadis E; Hinrichs B; Magnoni C; Fiorentini C; Majewski S; Ranki A; Proby CM; Stockfleth E; Trakatelli M;
    Br J Dermatol; 2012 Aug; 167 Suppl 2():36-42. PubMed ID: 22881586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinoma and actinic keratoses: patients' perceptions of their disease and current treatments.
    Berman B
    Int J Dermatol; 2001 Sep; 40(9):573-6. PubMed ID: 11737451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
    Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma.
    Olsen J; Themstrup L; De Carvalho N; Mogensen M; Pellacani G; Jemec GB
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():44-49. PubMed ID: 27519350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
    Tope WD; Nowfar-Rad M; Kist DA
    Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany.
    Kaskel P; Lange U; Sander S; Huber MA; Utikal J; Leiter U; Krähn G; Meurer M; Kron M
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):134-42. PubMed ID: 24684198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
    Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
    Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals.
    O'Grady A; O'Kelly P; Murphy GM; Leader M; Kay E
    Hum Pathol; 2004 Dec; 35(12):1549-55. PubMed ID: 15619216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
    Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
    Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.